维普期刊资源整合服务平台（V6.5）

96篇 您的检索式：作者名="FAYAD L"

选中清除导出查看参考文献查看引证文献引用追踪共5页首页上一页第1页下一页末页 /5 跳转

	题名	作者	年代	出处	被引量
1	MR cholangiopancreatography:evaluation of common pancreatic diseases显示文摘	Fayad L M Kowalski T Mitchell D G	2003	Radiol Clin North Am2003，41，：	1
2	Contrast enhancement by multi-scale adaptive histogram equalization显示文摘	Jin Yingpeng Fayad L Laine A	2001	SPIE proceedings series2001，4478，1：	1
3	Single administration of a fixed dose pegfilgrastim (Neulasta) in inducing neutrophil count recovery after 170 consecutive doses of ABVD chemotherapy in patients with Hodgkin lymphoma: safety of pegfilgrastim with q14-day chemotherapy regimens显示文摘	YounesA Fayad L RomagueraJ	2003	Proc Am Soc Hematol2003，102，11：	1
4	R-HCVAD/R-MTX-ARAC is an effective regimen for untreated diffuse large B-cell lymphoma(DLBCL)with aggressive features in patients younger than 60 years显示文摘	Fayad L Pro B Hagemeister F	2007	Blood2007，110，11：	1
5	High rate of durable remissions after treatment of newly diagnosed ag- gressive mantle - cell lymphoma with rituximab plus hyper - CVAD alternating with rituximab plus high - dose methotrexate and cytara- bine显示文摘	ROMAGUERA J E FAYAD L RODRIGUEZ M A	2005	J Clin Oncol2005，23，28：	1
6	High rate of durable re- missions after treatment of newly diagnosed aggressive mantle-cell lym- phoma with rituximab plus hyper-CVAD alternating with rltuximab plus high--dose methotrexate and cytarabine显示文摘	Romaguera JE Fayad L Rodriguez MA	2005	Clin Onco12005，23，：	1
7	Ten-year follow-up after intense chemoimmunotherapy with rituximab-hyper CVAD alternating with rituximab-high dose methotrexate/cytarabine(R-MA)and without stem cell transplantation in patients with untreated aggressive mantle cell lymphoma显示文摘	Romaguera JE Fayad LE Feng L	2010	Haematol2010，150，2：	1
8	Ofatumumab monotherapy in rituximab-refractory follicular lymphoma:results from a multicenter study显示文摘	Czuczman MS Fayad L Delwail V	2012	{H}Blood2012，，16：	1
9	Ofatumumab monotherapy in rituximab-refractory follicular lymphoma: results from a multicenter study显示文摘	Czuczman MS Fayad L Delwail V	2012	Blood2012，，：	1
10	Sihuximab, a novel anti- interleukin-6 monoclonal antibody, for Castleman's disease 显示文摘	Van Rhee F Fayad L Voorhees P	2010	J Clin Oncol2010，28，23：	1
11	Ofatumumab monotherapy in rituximab-refractory follicular lymphoma: results from a multicenter study显示文摘	Czuczman MS Fayad L Delwail V	2012	Blood2012，219，16：	1
12	Vascular malformations in the extremities:emphasis on MR imaging features that guide treatment options显示文摘	Fayad L Hazirolan T Bluemke D	2006	Skeletal Radiol2006，35，：	1
13	Humanized anti-CD20 antibody, veltuzumab, in refractory/recurrent non-Hodgkin's lymphoma: phase 1/11 results显示文摘	Morschhauser F Leonard JP Fayad L	2009	J Clin Oncol2009，27，20：	1
14	Humanized anti- CD20 antibody, vehuzumab, in refractory/recurrent non- Hodgkin' s lymphoma: Phase Ⅰ/Ⅱ results 显示文摘	Morschhauser F Leonard JP Fayad L	2009	J Clin Oncol2009，27，10：	1
15	Humanized anti-CD20 antibody, veltuzumab, in refractory/recurrent non-Hodgkin's lymphoma: phase Ⅰ/Ⅱ results显示文摘	Morschhauser F Leonard JP Fayad L	2009	J Clin Oncol2009，27，20：	1
16	High rate of durable remissions after treatment of newly diagnosed aggressive mantle-cell lymphoma with rituximab plus hyper-CVAD alternating with rituximab plus high-dose methotrexate and cytarabine显示文摘	Romaguera JE Fayad L Rodriguez MA	2005	J Clin Oncol2005，23，28：	1
17	High rate of durable remissions after treatment of newly diagnosed aggressive mantle-cell lymphoma with rituximab plus hyper- CVAD ahernating with rituximab plus high-dose methotrexate and cytarabine显示文摘	Romaguera JE Fayad L Rodriguez MA	2005	J Clin Oncol2005，23，28：	1
18	ASHAP: A regimen for cytoreduction of refractory or recurrent Hodgkin g disease 显示文摘	Rodriguez J Rodriguez MA Fayad L	1999	Blood1999，93，11：	1
19	Ofatumumab monotherapy in rituximab-refractory follicular lymphoma:results from a multicenter study 显示文摘	Czuczman MS Fayad L Delwail V	2012	Blood2012，119，16：	1
20	IGF-I and IGFBP-3serum levels in patients hospitalized for complications of liver cirrhosis显示文摘	Ronsoni MF Lazzarotto C Fayad L	2013	Ann Hepatol2013，12，3：	1

返回顶部每页显示：

共5页首页上一页第1页下一页末页 /5 跳转

互联网出版许可证新出网证(渝)字10号全国400电话 - 免长途话费

用户提示